search
Back to results

Dietary Protein Quality for Skeletal Muscle Anabolism in Older Adults

Primary Purpose

Sarcopenia, Dietary Protein, Resistance Exercise

Status
Recruiting
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Resistance Exercise
Protein supplementation
Sponsored by
University of Birmingham
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Sarcopenia

Eligibility Criteria

50 Years - 70 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Males and Females aged between 50-70 years
  • Accustomed to normal physical activity levels (averaging at least 7000 steps a day)
  • Healthy body mass (i.e., BMI 18-25 kg/m2)
  • General good health indicated by health questionnaire
  • Free from COVID-19 (SARS-CoV-2) symptoms.

Exclusion Criteria:

  • Habitually high consumers of protein (>1.6g/kg/day) assessed by habitual diet diary
  • Food allergies
  • Lidocaine allergy
  • Smoker
  • Bleeding Disorders
  • Chronic/systemic illnesses (i.e., renal failure, rheumatoid arthritis, diabetes, poor lung function, heart disease, cancer, uncontrolled hypertension)
  • Regular consumption of any analgesic or anti-inflammatory drugs. Taking medications mknown to affect muscle metabolis (e.g. beta-blockers, corticosteroids).

Sites / Locations

  • University of Birmingham, School of Sport, Exercise and Rehabilitation SciencesRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

High Quality Protein

Low Quality Protein

Arm Description

Participants will consume four high-quality protein containing meals per day (amounting to 1g/kg/day of protein) over a 10-day period. Each meal will contain 75:25 animal:plant protein with most of the animal protein from supplemental high-quality protein powder.

Participants will consume four low-quality protein containing meals per day (amounting to 1g/kg/day of protein) over a 10-day period. Each meal will contain 25:75 animal:plant protein with most of the plant protein from supplemental low-quality protein powder.

Outcomes

Primary Outcome Measures

Muscle protein synthesis using muscle biopsies and deuterated water enrichment.
Muscle protein synthesis will be assessed during the high-quality and low-quality intervention and compared between exercised and controlled leg.
Leg Strength using dynamometry
Evaluating change in leg strength, of trained leg, pre- and post-intervention with high-quality and low-quality protein condition
Neural activation using interpolated twitch
Assessing change in neural activation via non-invasive interpolated twitch technique of between exercised legs pre-and post intervention in both protein quality conditions
Muscle architecture using ultrasound
Using non-invasive ultrasound to determine change of muscle structure with training between protein quality conditions.

Secondary Outcome Measures

Appetite regulation using questionnaires
Assessing perceived hunger using a validated, 8 question, 100mm visual analogue scales.
Appetite regulation, blood
Assessing the secretion of hunger and appetite hormones within the blood after meals which contain high-quality versus low-quality protein.
Metabolic rate, metabolic cart
Evaluating alterations in energy expenditure before and after high-quality or low-quality protein containing meal using a metabolic cart.
Nitrogen balance from urine and dietary protein intake
Evaluating change in nitrogen balance between adhering to high-quality or low-quality protein diets over a 10-day period
Body composition using Duel- energy x-ray absorptiometry (DXA) scan.
Change in body composition (muscle mass, fat mass, bone mineral density) will be evaluated using a DXA scanner before and after adhering to single leg resistance exercise paired with either high-quality or low-quality protein diet.
Muscle fibre specific analysis using immunofluorescence microscopy.
Evaluate changes in fibre specific differences in the distribution and localisation of key anabolic markers between trained and untrained legs for both protein quality conditions.
Intramuscular signalling using western blotting
Evaluate changes in protein content and phosphorylation from the start to the end of the intervention.
Physical activity levels using accelerometery and pedometer
Monitoring of habitual and habitual physical activity to evaluate if intensity and duration of activity is similar between habitual and intervention.

Full Information

First Posted
September 29, 2022
Last Updated
October 5, 2022
Sponsor
University of Birmingham
Collaborators
Maastricht University
search

1. Study Identification

Unique Protocol Identification Number
NCT05574205
Brief Title
Dietary Protein Quality for Skeletal Muscle Anabolism in Older Adults
Official Title
The Importance of Dietary Protein Quality for Skeletal Muscle Anabolism in Older Adults
Study Type
Interventional

2. Study Status

Record Verification Date
September 2022
Overall Recruitment Status
Recruiting
Study Start Date
November 1, 2022 (Anticipated)
Primary Completion Date
October 1, 2023 (Anticipated)
Study Completion Date
December 1, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Birmingham
Collaborators
Maastricht University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Dietary proteins potently augment muscle protein synthesis. Because of poorer anabolic sensitivity with ageing, studies and guidelines recommend higher dietary protein intake for older adults. Although higher doses would benefit skeletal muscle remodelling, large protein consumption is not feasible for many older adults. To circumvent, high-protein quality which possesses a high amino acid profile and digestibility appears to have an emergent role for supporting anabolism. Since currently the best line of defence against age related muscle loss is resistance exercise training and regular protein consumption, emphasising high-quality protein ingestion, such as whey protein, within meals may be feasible and efficacious in supporting musculoskeletal remodelling in older adults, without requirement for large protein doses. The investigators propose that at low doses, high quality protein will have additive benefit to muscle protein synthesis compared to low-quality protein. Further, combining high-quality protein diets with resistance exercise training will have more profound benefits for muscle protein synthesis and muscle remodelling more so than low-quality protein diets.
Detailed Description
Participants will be randomly assigned to a 10-day dietary intervention consuming primarily animal proteins (high-quality condition) or primarily plant proteins (low-quality condition). In both conditions, participants will undertake supervised single-leg resistance exercise training every other day, amassing five days resistance exercise sessions during the study. The groups will aim to be matched and counterbalanced for gender. Equally for unilateral exercise randomisation for leg dominance will aim to be counterbalanced within both groups. Preliminary assessments: 5 days preceding the start of the dietary intervention, participants will report to the University of Birmingham, Sport, Exercise and Rehabilitation Science for the following: Health questionnaire Written informed consent Anthropometrics (Height and Weight) Body fat (bioelectrical impedance) Start measuring habitual activity (provided with an activity monitor and pedometer) Start measuring habitual diet (provided with diet diary) 2 days preceding the start of the dietary intervention, participants will report to the University of Birmingham, Sport, Exercise and Rehabilitation Science for the following: Saliva sample (participant gives own saliva sample in a tube) 10ml of blood taken for baseline measures (venepuncture by trained phlebotomist) Loading dose of D2O (stable isotope of water ingested in 8 small 50ml doses taken 1 hour apart throughout the day) Find 1 repetition maximum (1RM) during unilateral knee extension. Dietary intervention each day throughout 10-day intervention participants will provide a saliva sample and then consume a top up dose of D2O, continue wearing an activity tracker and keep a diet diary to record eating times of provided meals. Meals will be individualised to body weight for each individual to achieve a moderate protein intake of which will then consist of primarily higher quality or lower quality proteins. Day 0 (first day of diet), participants will report to the University of Birmingham, Sport, Exercise and Rehabilitation Science at 0800h after fasting >10 hours the night prior for the following: Resting metabolic rate (Laying down for 30 minutes to assess gaseous exchange while wearing a mask) Muscle architecture (using non-invasive ultrasonography) Whole-body composition assessment (DXA scan) Bilateral muscle biopsies (small amount of muscle will be taken from the muscle in the thigh (vastus lateralis) by a trained person from the left and right leg, under local anaesthetic) Maximal muscle strength (isometric dynamometry) and neural activation (interpolated twitch) during maximal muscle contraction on both legs in series. Serial blood samples will be taken with a single cannulisation and 8 10ml blood draws taken throughout the visit (before and after consuming a breakfast which is either higher or lower in protein quality, according to the randomised condition). Perceived appetite will be assessed during the visit, before and after breakfast, using visual analogue scales Urine collection tub will be provided to collect urine over the next 24-hours. After consuming specified breakfast on this visit, participants will continue to eat meals given to them according to their random allocation of either higher or lower quality protein diets. Day 1, 3, 5, 7, 9 Participants will report to the University of Birmingham, Sport, Exercise and Rehabilitation Science to undergo single-leg resistance exercise on a knee extension machine. Eight sets will be completed on the machine at each visit at 75% of 1RM (determined during preliminary visits and will be supervised). On day 9, the participant will be given a urine collection tub to collect urine over the next 24-hours. Day 10 (Diet finishing during this visit), participants will report to the University of Birmingham, Sport, Exercise and Rehabilitation Science at 0800h after fasting >10 hours the night prior for the following assessments: Resting metabolic rate (Laying down for 30 minutes to assess gaseous exchange while wearing a mask) Whole-body composition assessment (DXA scan) Muscle Architecture (using non-invasive ultrasonography) Maximal muscle strength (Isometric Dynamometry) and neural activation during maximal muscle contraction (Interpolated twitch) Bilateral muscle biopsies (small amount of muscle will be taken from the muscle in the thigh (vastus lateralis) from the left and right leg under local anaesthetic Serial blood samples will be taken with a single cannulisation and 8 10ml blood draws taken throughout the visit (before and after consuming the final meal of the diet which is the breakfast which is either higher or lower in protein quality, according to the randomised condition) Perceived appetite will be assessed during the visit, before and after breakfast, using visual analogue scales.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sarcopenia, Dietary Protein, Resistance Exercise

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Participants will be randomly assigned to either the high-quality or low-quality condition. Within both conditions single-leg resistance exercise will be undertaken meaning the other non-exercise leg for each participant will act as their own internal control.
Masking
Participant
Masking Description
The participant will not know which condition they are under due to the contribution of animal and plant based elements within the diet, the conditions are not immediately obvious. Further, the higher and lower quality supplemental drinks have been made so the taste and texture of which are not discernible. The randomisation and counterbalancing will be done by a researcher separate to the project, using anonymised participant codes. The condition participants are under will be also completed before inducting participants. Researchers will be blinded to the condition and which leg was exercised during the analysis.
Allocation
Randomized
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
High Quality Protein
Arm Type
Experimental
Arm Description
Participants will consume four high-quality protein containing meals per day (amounting to 1g/kg/day of protein) over a 10-day period. Each meal will contain 75:25 animal:plant protein with most of the animal protein from supplemental high-quality protein powder.
Arm Title
Low Quality Protein
Arm Type
Experimental
Arm Description
Participants will consume four low-quality protein containing meals per day (amounting to 1g/kg/day of protein) over a 10-day period. Each meal will contain 25:75 animal:plant protein with most of the plant protein from supplemental low-quality protein powder.
Intervention Type
Other
Intervention Name(s)
Resistance Exercise
Other Intervention Name(s)
Single-leg resistance exercise
Intervention Description
Supervised single-leg (unilateral) exercise will be undertaken every other day throughout the dietary intervention
Intervention Type
Dietary Supplement
Intervention Name(s)
Protein supplementation
Intervention Description
Participants will consume a protein supplement alongside a provided diet to control protein amount and quality.
Primary Outcome Measure Information:
Title
Muscle protein synthesis using muscle biopsies and deuterated water enrichment.
Description
Muscle protein synthesis will be assessed during the high-quality and low-quality intervention and compared between exercised and controlled leg.
Time Frame
0-10 days
Title
Leg Strength using dynamometry
Description
Evaluating change in leg strength, of trained leg, pre- and post-intervention with high-quality and low-quality protein condition
Time Frame
0-10 days
Title
Neural activation using interpolated twitch
Description
Assessing change in neural activation via non-invasive interpolated twitch technique of between exercised legs pre-and post intervention in both protein quality conditions
Time Frame
0-10 days
Title
Muscle architecture using ultrasound
Description
Using non-invasive ultrasound to determine change of muscle structure with training between protein quality conditions.
Time Frame
0-10 days
Secondary Outcome Measure Information:
Title
Appetite regulation using questionnaires
Description
Assessing perceived hunger using a validated, 8 question, 100mm visual analogue scales.
Time Frame
0-10 days (3 hours postprandial)
Title
Appetite regulation, blood
Description
Assessing the secretion of hunger and appetite hormones within the blood after meals which contain high-quality versus low-quality protein.
Time Frame
0-10 days (3 hours postprandial)
Title
Metabolic rate, metabolic cart
Description
Evaluating alterations in energy expenditure before and after high-quality or low-quality protein containing meal using a metabolic cart.
Time Frame
0-10 days
Title
Nitrogen balance from urine and dietary protein intake
Description
Evaluating change in nitrogen balance between adhering to high-quality or low-quality protein diets over a 10-day period
Time Frame
0-10 days (24-hour urine collection)
Title
Body composition using Duel- energy x-ray absorptiometry (DXA) scan.
Description
Change in body composition (muscle mass, fat mass, bone mineral density) will be evaluated using a DXA scanner before and after adhering to single leg resistance exercise paired with either high-quality or low-quality protein diet.
Time Frame
0-10 days
Title
Muscle fibre specific analysis using immunofluorescence microscopy.
Description
Evaluate changes in fibre specific differences in the distribution and localisation of key anabolic markers between trained and untrained legs for both protein quality conditions.
Time Frame
0-10 days
Title
Intramuscular signalling using western blotting
Description
Evaluate changes in protein content and phosphorylation from the start to the end of the intervention.
Time Frame
0-10 days
Title
Physical activity levels using accelerometery and pedometer
Description
Monitoring of habitual and habitual physical activity to evaluate if intensity and duration of activity is similar between habitual and intervention.
Time Frame
-5-10 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Males and Females aged between 50-70 years Accustomed to normal physical activity levels (averaging at least 7000 steps a day) Healthy body mass (i.e., BMI 18-25 kg/m2) General good health indicated by health questionnaire Free from COVID-19 (SARS-CoV-2) symptoms. Exclusion Criteria: Habitually high consumers of protein (>1.6g/kg/day) assessed by habitual diet diary Food allergies Lidocaine allergy Smoker Bleeding Disorders Chronic/systemic illnesses (i.e., renal failure, rheumatoid arthritis, diabetes, poor lung function, heart disease, cancer, uncontrolled hypertension) Regular consumption of any analgesic or anti-inflammatory drugs. Taking medications mknown to affect muscle metabolis (e.g. beta-blockers, corticosteroids).
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Leigh Breen, PhD
Phone
121 414 4109
Ext
+44
Email
l.breen@bham.ac.uk
First Name & Middle Initial & Last Name or Official Title & Degree
Marie Korzepa, MSc
Email
mxk098@student.bham.ac.uk
Facility Information:
Facility Name
University of Birmingham, School of Sport, Exercise and Rehabilitation Sciences
City
Edgbaston
State/Province
West Midlands
ZIP/Postal Code
B15 2TT
Country
United Kingdom
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Leigh Breen, PhD
Phone
01214144109
Ext
+44
Email
l.breen@bham.ac.uk
First Name & Middle Initial & Last Name & Degree
Marie Korzepa, MSc

12. IPD Sharing Statement

Learn more about this trial

Dietary Protein Quality for Skeletal Muscle Anabolism in Older Adults

We'll reach out to this number within 24 hrs